- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 5/26 - Androgens
Patent holdings for IPC class A61P 5/26
Total number of patents in this class: 217
10-year publication summary
|
6
|
12
|
12
|
12
|
14
|
16
|
11
|
14
|
22
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| University of Tennessee Research Foundation | 755 |
11 |
| Lipocine Inc. | 116 |
10 |
| Antares Pharma, Inc. | 171 |
7 |
| Novartis AG | 10463 |
6 |
| Sepah, Saviz Cameron | 6 |
6 |
| Takeda Pharmaceutical Company Limited | 2713 |
5 |
| Eli Lilly and Company | 3964 |
5 |
| Tolmar, Inc. | 47 |
5 |
| Trimel BioPharma SRL | 7 |
5 |
| Azurity Pharmaceuticals, Inc. | 236 |
5 |
| Sumitomo Chemical Company, Limited | 9053 |
4 |
| Provincial Health Services Authority | 191 |
4 |
| TOLMAR International Limited | 85 |
4 |
| Changchun Genescience Pharmaceutical Co., Ltd. | 107 |
4 |
| Pfizer Inc. | 3374 |
3 |
| Endorecherche, Inc. | 21 |
3 |
| Fundacio Institut de Recerca Biomedica (irb Barcelona) | 73 |
3 |
| Institucio Catalana de Recerca I Estudis Avancats | 375 |
3 |
| Ligand Pharmaceuticals Incorporated | 170 |
3 |
| Sun Yat-sen University | 703 |
3 |
| Other owners | 118 |